Third, CCL2 blockade is known to prime cell response to infection and to reduce cell-killing properties which are underdeveloped in preterm infants and are thereby at increased risk for nosocomial infections due to their immature immune system. This evidence concerns the gene CCL2 and nosocomial infection.